Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Larry Dreher who wrote (217)	2/19/1998 11:27:00 AM
From: Scott	Read Replies (1) \| Respond to of 1127

You got my tone right. While I do believe that what HGS is doing falls within the letter of the patent laws, it seems that it is outside the intent of those laws. How can something be patentable that is just fed out of a machine with no clues as to its real function? It is circular reasoning to say that a piece of the human genome is useful by virtue of the fact that it is a piece of the human genome. Nevertheless, I think they are going to get away with it. While I believe that it is a travesty that they will be able to get extortion money from the developers of the real therapeutic drugs, I have bought a wad of shares in HGS, and sunk some of my kids' education money in it as well.